Previous Close | 39.39 |
Open | 39.81 |
Bid | 0.00 x 3200 |
Ask | 0.00 x 800 |
Day's Range | 39.61 - 41.51 |
52 Week Range | 35.34 - 122.99 |
Volume | |
Avg. Volume | 2,251,038 |
Market Cap | 7.237B |
Beta (5Y Monthly) | 1.24 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.32 |
Earnings Date | Jul 26, 2022 - Aug 01, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 96.53 |
Subscribe to Yahoo Finance Plus to view Fair Value for EXAS
Exact Sciences' (EXAS) legacy Screening business is growing on impressive Cologuard volume growth and revenue contributions from the PreventionGenetics acquisition.
Yahoo Finance’s Alexandra Semenova joins the Live show to discuss ARKK ETF seeing is longest inflow streak in over one year as inflation continues.
Exact Sciences (EXAS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.